Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126368852 | 12636885 | 2 | F | 20160809 | 20160809 | 20160811 | EXP | SG-PFIZER INC-2016378133 | PFIZER | TAN, J.. NONSTEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) EXACERBATED RESPIRATORY DISEASE PHENOTYPE: TOPICAL NSAID AND ASTHMA CONTROL - A POSSIBLE OVERSIGHT LINK.. RESPIRATORY MEDICINE. 2016;118:1-3 | 47.00 | YR | Y | 0.00000 | 20160811 | MD | SG | SG |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126368852 | 12636885 | 1 | PS | PIROXICAM. | PIROXICAM | 1 | UNK | U | 18147 | GEL | |||||||||
| 126368852 | 12636885 | 2 | SS | KETOPROFEN. | KETOPROFEN | 1 | UNK | U | 0 | ||||||||||
| 126368852 | 12636885 | 3 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | UNK | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126368852 | 12636885 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126368852 | 12636885 | Aspirin-exacerbated respiratory disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |